Barcelona, Spain

Mónica García López

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Laboratorios Del Dr. Esteve S.a.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mónica García López. Retrieved from https://idiyas.com/inventor/mónica-garcía-lópez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mónica García López: Innovator in Sigma Receptor Inhibitors

Introduction

Mónica García López is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmacology, particularly through his work on sigma receptor inhibitors. His innovative approach has led to the development of compounds that have potential therapeutic applications.

Latest Patents

Mónica holds 1 patent related to sigma receptor inhibitors. This invention refers to compounds of general formula (I) that exhibit pharmacological activity towards the sigma receptor. The patent also details processes for the preparation of these compounds, pharmaceutical compositions that include them, and their use in treating or preventing diseases associated with the sigma receptor.

Career Highlights

Mónica is currently associated with Laboratorios del Dr. Esteve S.A., where he continues to advance his research and development efforts. His work has been instrumental in exploring new therapeutic avenues and enhancing the understanding of sigma receptors in medical science.

Collaborations

Mónica has collaborated with notable colleagues, including Antoni Torrens Jover and José Luis Díaz Fernández. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mónica García López is a key figure in the development of sigma receptor inhibitors, contributing valuable insights and advancements in pharmacology. His work exemplifies the impact of innovative research on healthcare and disease treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…